Literature DB >> 21565974

Rotation thromboelastography (ROTEM) parameters are influenced by age, gender, and oral contraception.

C Sucker1, K Tharra, J Litmathe, R E Scharf, R B Zotz.   

Abstract

Rotation thromboelastography (ROTEM) is a screening method that allows the rapid detection of plasma- and platelet-related haemostatic abnormalities. To use this procedure more efficiently, reference values depending on gender, age, and oral contraception are required. In this study, five cohorts of healthy subjects were examined by ROTEM upon activation of the extrinsic or intrinsic pathway of coagulation, or recalcification alone. The cohorts comprised male subjects below (1) and above (2) 45 years of age, female subjects below 45 years of age with (3) or without (4) oral contraception, and female subjects above 45 years (5) without hormone replacement therapy. A significant influence of gender, age, and oral contraception on parameters determined by ROTEM was observed. Thus, adjustment for age, gender, and oral contraception is required when ROTEM is used to screen for distinct abnormalities of haemostasis.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21565974     DOI: 10.1177/0267659111407695

Source DB:  PubMed          Journal:  Perfusion        ISSN: 0267-6591            Impact factor:   1.972


  4 in total

1.  Effect of synthetic colloid administration on coagulation in healthy dogs and dogs with systemic inflammation.

Authors:  V Gauthier; M K Holowaychuk; C L Kerr; A M E Bersenas; R Darren Wood
Journal:  J Vet Intern Med       Date:  2015-01       Impact factor: 3.333

2.  Investigation of Blood Coagulation Using Impedance Spectroscopy: Toward Innovative Biomarkers to Assess Fibrinogenesis and Clot Retraction.

Authors:  Giulia D'Ambrogio; Omar Zahhaf; Minh-Quyen Le; Yves Gouriou; Laurie Josset; Vincent Pialoux; Patrick Lermusiaux; Jean-Fabien Capsal; Pierre-Jean Cottinet; Nellie Della Schiava
Journal:  Biomedicines       Date:  2022-07-29

3.  Combined Administration of Fibrinogen and Factor XIII Concentrate Does Not Improve Dilutional Coagulopathy Superiorly Than Sole Fibrinogen Therapy: Results of an In-Vitro Thrombelastographic Study.

Authors:  Emmanuel Schneck; Marcus Muelich; Melanie Markmann; Fabian Edinger; Nina Cooper; Annette Moeller; Gregor Bein; Andreas Hecker; Christian Koch; Michael Sander; Matthias Wolff
Journal:  J Clin Med       Date:  2021-05-12       Impact factor: 4.241

4.  Validation of a modified thromboelastometry approach to detect changes in fibrinolytic activity.

Authors:  Gerhardus J A J M Kuiper; Marie-Claire F Kleinegris; René van Oerle; Henri M H Spronk; Marcus D Lancé; Hugo Ten Cate; Yvonne M C Henskens
Journal:  Thromb J       Date:  2016-01-14
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.